You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2024

AbstractFullPdf
Dec 2019020
Jan 2020020
Feb 2020010
Mar 2020010
May 2020020
Jun 20200100
Jul 2020030
Aug 2020010
Sep 2020050
Nov 2020020
Dec 2020010
Jan 2021030
Feb 2021011
Mar 2021010
Apr 2021020
Jun 2021010
Jul 2021010
Aug 2021011
Sep 2021010
Oct 2021041
Nov 2021013
Dec 2021030
Jan 2022040
Feb 2022020
Mar 2022010
Apr 2022030
May 20220102
Jun 2022060
Jul 2022091
Aug 2022051
Sep 2022050
Oct 2022010
Nov 2022070
Dec 2022070
Jan 2023020
Feb 2023030
Mar 2023010
May 2023001
Jul 2023011
Aug 2023010
Sep 2023020
Oct 2023011
Nov 2023030
Dec 2023061
Jan 2024030
Feb 2024060
Mar 2024020
Apr 2024030
May 2024061
Jun 2024032
Jul 2024074
Aug 2024071
Sep 2024031
Total016923